Japan's SoftBank to take $2 billion stake in computer chip maker Intel
Shares in SoftBank fell 4% Tuesday in Tokyo following the announcement, which coincided with unconfirmed reports that President Donald Trump is considering having the U.S. government buy a stake in the chip maker.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
27 minutes ago
- Yahoo
US Roasters Shun Coffee From Brazil After 50% Tariffs Kick In
(Bloomberg) -- American coffee buyers are shunning fresh deals with top grower Brazil after President Donald Trump's 50% tariff took effect this month. Chicago Schools Seeks $1 Billion of Short-Term Debt as Cash Gone A Photographer's Pipe Dream: Capturing New York's Vast Water System A London Apartment Tower With Echoes of Victorian Rail and Ancient Rome Why New York City Has a Fleet of New EVs From a Dead Carmaker Princeton Plans New Budget Cuts as Pressure From Trump Builds Companies are avoiding new contracts and looking for wiggle room in existing ones to avoid having to pay the higher levies, according to a dozen brokers, roasters and exporters contacted by Bloomberg. Some US buyers are asking for extended shipping timelines in the hopes that tariffs may be eased later, according to Brazil's exporter group Cecafé. Deals between the US and Brazil have 'totally stalled,' said coffee broker Thiago Cazarini. 'No one's really buying anything.' About a third of America's unroasted coffee typically comes from Brazil, a country Trump has been immersed in a trade conflict with, in part due to what he calls the 'politically motivated persecution' of former Brazilian President Jair Bolsonaro. A political ally of Trump's, Bolsonaro faces trial for an attempted coup against the government of President Luiz Inácio Lula da Silva, who defeated Bolsonaro in a 2022 election. Trump first announced 10% tariffs on Brazil and other countries in April, before imposing 50% levies on the South American agricultural power that kicked in on Aug. 6. One roaster, Florida-based Zaza Coffee, gets about a quarter of its beans from Brazil and currently has 14 to 16 weeks left of those supplies. After the beans are used up, the company is looking to replace them with coffee from Central America, Peru and Mexico, said JP Juarez, Zaza's director of coffee innovation. 'We have a certain window within this 14 weeks that maybe something can change in the case of the tariffs,' Juarez said. But 'in the scenario of keeping the tariffs at those levels, probably we are not going to ask for Brazilian coffee.' Many roasters are reluctant to change longstanding blends on what could turn out to be a short-term policy. The country's dominant share makes its beans nearly irreplaceable, with few alternative origins able to match its volumes, according to Christian Wolthers, chief executive officer of Florida-based importer Wolthers Douqué. Roasters may also not want to alter the profile of the blends customers are accustomed to. Brazil is the world's top exporter of arabica, which is considered smoother than robusta and is the only bean used by coffeehouse chain Starbucks Corp. 'Roasters have blends that they like to keep as consistent as they can in any given cost environment,' Rabobank analyst Jim Watson said. Even so, coffee trade between the US and Brazil may continue to slow, in line with a trend seen so far this year. The Cuban-style coffee brand Café Aroma is among the roasters 'working to import coffees where the applicable tariff has more predictability,' vice president Bernadette Gerrity said. It's also buying more coffee futures to help protect against higher costs. Colombia, Vietnam and Honduras are the next biggest sources of coffee for the US in terms of quantity, according to the Department of Agriculture. Vietnam primarily produces robusta, a cheaper variety that most Americans only know from instant coffee. US imports of those beans could climb to 'historical highs' as tariffs on the nation are only 20%, according to Laleska Moda, market intelligence analyst at Hedgepoint Global Markets. The US could also boost imports from Indonesia and Uganda, which have substantially lower tariffs than Brazil, she said. Limited offers for Honduran coffee are already priced 30 to 40 cents per pound above the futures market, while Colombian exporters haven't been offering prices at all in case the market surges later, said Tomas Araujo, a senior trader at StoneX. A shift away from Brazilian beans in the US would likely divert more of those supplies to Europe, offering relief for buyers there that are seeking traceable beans to comply with the bloc's upcoming deforestation rules, according to Dave Behrends, head of trading at Sucafina SA. More beans would also go to the growing coffee market in China, leaving US roasters facing a pricier market. While New York-based Gregorys Coffee is lucky to have had its last shipment from Brazil arrive on Aug. 2 before the higher tariffs kicked in — leaving it supplied until mid-November — it will eventually need to import another batch it already contracted at the higher rate, said CEO Gregory Zamfotis. The company, as well as other smaller roasters, are bracing for the impact. 'Absorbing a 10% tariff is nearly impossible for a small business to do entirely on its own,' said Daria Whalen, the director of coffee at San Francisco-based Ritual Coffee Roasters. 'Some of that has to be passed to customers — and 50% feels staggering and insurmountable.' --With assistance from Anuradha Raghu. Foreigners Are Buying US Homes Again While Americans Get Sidelined What Declining Cardboard Box Sales Tell Us About the US Economy Women's Earnings Never Really Recover After They Have Children Americans Are Getting Priced Out of Homeownership at Record Rates Yosemite Employee Fired After Flying Trans Pride Flag ©2025 Bloomberg L.P. Sign in to access your portfolio
Yahoo
27 minutes ago
- Yahoo
Walgreens Grows Specialty Pharmacy Network To Meet Rising Demand For Complex Therapies
Walgreens Boots Alliance, Inc. (NASDAQ:WBA) shares edged slightly higher on Tuesday. The firm's specialty pharmacy arm announced a significant expansion of its drug distribution network. The company revealed that Walgreens Specialty Pharmacy has broadened its limited distribution drug (LDD) portfolio to cover 265 therapies, strengthening its role as one of the most extensive specialty pharmacy networks in the are highly regulated medicines distributed through selected specialty pharmacies, often involving complex regimens, high costs, or special handling requirements. Unlike pharmacies linked to pharmacy benefit managers, Walgreens Specialty Pharmacy operates independently, which allows it to work flexibly with insurers, pharmaceutical manufacturers, healthcare providers, and other partners. This structure makes it possible to expand its collaborations without being restricted by direct PBM ties. 'As the limited distribution drug network continues to grow, our specialty pharmacy teams across the country are equipped to support manufacturers in getting their medications to patients who need it most,' said Tracey James, RPh, chief operating officer of Walgreens Specialty Pharmacy. She emphasized that independence helps the company engage broadly across the healthcare system. Specialty medicine has become one of the fastest-growing healthcare sectors, with roughly three-quarters of newly developed drugs falling into this category. To address these challenges, Walgreens employs a nationwide team of pharmacists, nurses, patient advocates, and insurance experts dedicated to supporting patients with unique conditions and complex treatment needs. Among the therapies added in 2025 are Yeztugo (lenacapavir) from Gilead Sciences, Inc. (NASDAQ:GILD), which is the first FDA-approved twice-yearly preventive treatment for HIV; Nemluvio (nemolizumab) from Galderma (OTC:GALDY), targeting moderate-to-severe atopic dermatitis and prurigo nodularis; and Imkeldi (imatinib) from Shorla Oncology, a therapy for certain blood cancers and related diseases. According to Benzinga Pro, WBA stock has gained over 10% in the past year. Investors can gain exposure to the stock via Invesco S&P 500 Equal Weight Consumer Staples ETF (NYSE:RSPS). Price Action: WBA stock is trading higher by 0.21% to $12.03 at last check Tuesday. Read Next: Image via Shutterstock UNLOCKED: 5 NEW TRADES EVERY WEEK. Click now to get top trade ideas daily, plus unlimited access to cutting-edge tools and strategies to gain an edge in the markets. Get the latest stock analysis from Benzinga? This article Walgreens Grows Specialty Pharmacy Network To Meet Rising Demand For Complex Therapies originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
27 minutes ago
- Yahoo
Here's What Lifted Turning Point Brands (TPB)
Meridian Funds, managed by ArrowMark Partners, released its 'Meridian Small Cap Growth Fund' second-quarter 2025 investor letter. A copy of the letter can be downloaded here. During the quarter, equity markets experienced a significant rebound, increasing by 23% from their lowest points within the period to reach new record highs. In this environment, the fund returned 6.96% (net) in the second quarter compared to the Russell 2000 Growth Index's 11.97% return. In addition, please check the fund's top five holdings to know its best picks in 2025. In its second-quarter 2025 investor letter, Meridian Small Cap Growth Fund highlighted stocks such as Turning Point Brands, Inc. (NYSE:TPB). Headquartered in Louisville, Kentucky, Turning Point Brands, Inc. (NYSE:TPB) manufactures, markets, and distributes branded consumer products. The one-month return of Turning Point Brands, Inc. (NYSE:TPB) was 25.45%, and its shares gained 146.44% of their value over the last 52 weeks. On August 18, 2025, Turning Point Brands, Inc. (NYSE:TPB) stock closed at $98.58 per share, with a market capitalization of $1.778 billion. Meridian Small Cap Growth Fund stated the following regarding Turning Point Brands, Inc. (NYSE:TPB) in its second quarter 2025 investor letter: "Turning Point Brands, Inc. (NYSE:TPB), a producer of branded consumer products including alternative smoking accessories, delivered solid results during the quarter. Strong execution and rising market share in its tobacco-free nicotine pouches contributed to strong top-line growth and improved profitability. The stock responded accordingly, and we trimmed our position during the quarter based on our valuation discipline." A worker athlete with a rolling paper held in hand, smoking from the finished cigar. Turning Point Brands, Inc. (NYSE:TPB) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 38 hedge fund portfolios held Turning Point Brands, Inc. (NYSE:TPB) at the end of the first quarter, which was 30 in the previous quarter. Turning Point Brands, Inc.'s (NYSE:TPB) second quarter revenue increased 25% to $116.6 million. While we acknowledge the potential of Turning Point Brands, Inc. (NYSE:TPB) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. In another article, we covered Turning Point Brands, Inc. (NYSE:TPB) and shared the list of best bear market stocks to buy according to analysts. In addition, please check out our hedge fund investor letters Q2 2025 page for more investor letters from hedge funds and other leading investors. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
